Ben-Hur E, Rywkin S, Rosenthal I, Geacintov N E, Horowitz B
Virus Inactivation Laboratory, Lindsley F. Kimball Research Institute, New York Blood Center, New York, USA.
Transfusion. 1995 May;35(5):401-6. doi: 10.1046/j.1537-2995.1995.35595259150.x.
Photodynamic treatment of red cells (RBCs) with phthalocyanines and red light inactivates lipid-enveloped viruses, such as vesicular stomatitis virus (VSV) and human immunodeficiency virus. To protect RBCs from photodynamic damage, type I free radical quenchers, such as mannitol, which did not affect virus inactivation, were added.
Aluminum phthalocyanine tetrasulfonate (AIPcS4) was found to inactivate VSV at a rate one-fourth that of the silicon phthalocyanines (Pc 4 and Pc 5). However, the latter also caused more RBC damage. To protect RBCs against this photodynamic damage, Trolox, a water-soluble vitamin E analogue, was used. RBC damage was measured as potassium leakage or hemolysis during storage after treatment. In addition, reduction in negative surface charge on RBCs was measured immediately after treatment, and the effect of Trolox on VSV inactivation in RBCs was evaluated.
Trolox at a concentration of 5 mM was found to reduce potassium leakage during storage after Pc 4 and AIPcS4 photodynamic treatment of RBCs. Hemolysis during storage of RBC concentrates treated with Pc 4 or Pc 5 was drastically reduced by the addition of 5 mM Trolox prior to light exposure. At the same concentration, Trolox inhibited the reduction of negative surface charges on RBCs following Pc 4 and Pc 5 photodynamic treatment. Under these conditions, VSV inactivation by photodynamic treatment with all phthalocyanines was not affected by Trolox. In aqueous solution, Trolox formed a complex with AIPcS4, thus quenching the excited triplet state of AIPcS4 at a constant rate of 8.8 x 10(6) per M per second.
These findings indicate that Trolox protects RBCs from phthalocyanine-photosensitized damage without affecting virus kill. The addition of Trolox would be beneficial for improving the quality of RBCs subjected to photodynamic treatment.
用酞菁和红光对红细胞(RBC)进行光动力处理可使脂质包膜病毒失活,如水泡性口炎病毒(VSV)和人类免疫缺陷病毒。为保护红细胞免受光动力损伤,添加了I型自由基淬灭剂,如甘露醇,其不影响病毒灭活。
发现四磺酸铝酞菁(AIPcS4)使VSV失活的速率是硅酞菁(Pc 4和Pc 5)的四分之一。然而,后者也会对红细胞造成更多损伤。为保护红细胞免受这种光动力损伤,使用了一种水溶性维生素E类似物Trolox。红细胞损伤通过处理后储存期间的钾泄漏或溶血来衡量。此外,处理后立即测量红细胞表面负电荷的减少,并评估Trolox对红细胞中VSV灭活的影响。
发现浓度为5 mM的Trolox可减少Pc 4和AIPcS4对红细胞进行光动力处理后储存期间的钾泄漏。在用Pc 4或Pc 5处理的红细胞浓缩物储存期间,通过在光照前添加5 mM Trolox,溶血现象大幅减少。在相同浓度下,Trolox抑制了Pc 4和Pc 5光动力处理后红细胞表面负电荷的减少。在这些条件下,所有酞菁光动力处理对VSV的灭活不受Trolox影响。在水溶液中,Trolox与AIPcS4形成复合物,从而以8.8×10⁶每摩尔每秒的恒定速率淬灭AIPcS4的激发三重态。
这些发现表明,Trolox可保护红细胞免受酞菁光致敏损伤,而不影响病毒杀灭。添加Trolox将有助于提高接受光动力处理的红细胞的质量。